Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT04656067

Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate

Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate to Reduce Blood Loss Intraoperative and Post Operative During Elective Cesarean Section

Sponsor: Egymedicalpedia

Conditions Blood Loss, Postoperative Blood Loss, Surgical

Interventions Oxytocin ,Tranexamic acid and Ethamsylate

Updated 6 times since 2021 Last updated: Mar 1, 2022 Started: Apr 1, 2020 Primary completion: Oct 1, 2020 Completion: Nov 10, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Blood Loss, Postoperative and Blood Loss, Surgical, this trial is completed. The trial is conducted by Egymedicalpedia and has accumulated 6 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Mar 2021 — Apr 2022 [monthly]

Completed PHASE1_PHASE2
Feb 2021 — Mar 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2021 — Feb 2021 [monthly]

Completed PHASE1_PHASE2

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Egymedicalpedia

Data source: Egymedicalpedia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt